| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/06/2010 | US20100111990 Polypeptide Recognized by Anti HIV-1 GP41 Antibodies Isolated from Highly HIV-1 Exposed, Non Infected Women |
| 05/06/2010 | US20100111989 Rsv f-protein and its use |
| 05/06/2010 | US20100111988 Small peptide for anti-angiogenesis and use thereof |
| 05/06/2010 | US20100111987 Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject |
| 05/06/2010 | US20100111986 WT1 HLA Class II-Binding Peptides and Compositions and Methods Comprising Same |
| 05/06/2010 | US20100111985 Vaccine compositions and methods of use |
| 05/06/2010 | US20100111984 Nanospheres encapsulating bioactive material and method for formulation of nanospheres |
| 05/06/2010 | US20100111983 Method for Using Lowstrength Electric Field Network (LSEN) and Immunosuppressive Strategies to Mediate Immune Responses |
| 05/06/2010 | US20100111982 Rheumatoid arthritis t cell vaccine |
| 05/06/2010 | US20100111981 Synthetic monodisperse hemozoin crystals preparation and uses thereof |
| 05/06/2010 | US20100111980 Binding partners of antibodies specific for dendritic cell antigens |
| 05/06/2010 | US20100111979 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 05/06/2010 | US20100111978 Conjugates between a variant staphylococcal enterotoxin e superantigen and a targeting antibody that binds to a cancer-associated cell surface structure |
| 05/06/2010 | US20100111977 Methods and compositions for treatment of myotonic dystrophy |
| 05/06/2010 | US20100111976 Targeted biocides |
| 05/06/2010 | US20100111975 Monoclonal Antibodies for Treatment of Cancer |
| 05/06/2010 | US20100111974 Treatment of Cachexia |
| 05/06/2010 | US20100111973 Methods for treating mica-related disorders |
| 05/06/2010 | US20100111972 Method for preventing or treating opiate tolerance and dependence |
| 05/06/2010 | US20100111971 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases |
| 05/06/2010 | US20100111970 Anti-NGF Antibodies and Methods Using Same |
| 05/06/2010 | US20100111969 Il-4 receptor and il-13 as prognostic markers for colon and pancreas tumors |
| 05/06/2010 | US20100111968 Methods for Mediating Fibrotic Response |
| 05/06/2010 | US20100111967 Bispecific anti-vegf/anti-ang-2 antibodies |
| 05/06/2010 | US20100111966 Engineered anti-il-23p19 antibodies |
| 05/06/2010 | US20100111965 Combination therapy |
| 05/06/2010 | US20100111964 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 05/06/2010 | US20100111963 Method for treating age-related macular degeneration |
| 05/06/2010 | US20100111962 Determining and Reducing Immunoresistance to a Botulinum Toxin Therapy Using Botulinum Toxin B Peptides |
| 05/06/2010 | US20100111961 Compositions and methods for diagnosing or treating psoriasis |
| 05/06/2010 | US20100111960 Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 05/06/2010 | US20100111959 Engineered anti-il-13 antibodies, compositions, methods and uses |
| 05/06/2010 | US20100111958 Notch-Binding Agents and Antagonists and Methods of Use Thereof |
| 05/06/2010 | US20100111957 Methods of diagnosing and treating cytomegalovirus diseases |
| 05/06/2010 | US20100111956 antigen polypeptide for the diagnosis and/or treatment of ovarian cancer |
| 05/06/2010 | US20100111955 Hedgehog signaling pathway proteins and uses thereof |
| 05/06/2010 | US20100111954 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease |
| 05/06/2010 | US20100111953 Antibodies that immunospecifically bind to b lymphocyte stimulator |
| 05/06/2010 | US20100111952 Treatment of autoimmune disorders |
| 05/06/2010 | US20100111951 ADAM-9 Modulators |
| 05/06/2010 | US20100111950 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease |
| 05/06/2010 | US20100111949 Methods and compositions for the treatment of proliferative diseases |
| 05/06/2010 | US20100111948 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 05/06/2010 | US20100111947 Pharmaceutical composition comprising antibody composition which specifically binds to ganglioside gm2 |
| 05/06/2010 | US20100111946 Inhibiting activation with human anti-factor c3 antibodies and use thereof |
| 05/06/2010 | US20100111945 Novel uses |
| 05/06/2010 | US20100111944 Method of diagnosing, classifying and treating endometrial cancer and precancer |
| 05/06/2010 | US20100111943 Compositions and methods for inhibiting cancer metastasis |
| 05/06/2010 | US20100111942 Combination therapy for the treatment of ocular neovascular disorders |
| 05/06/2010 | US20100111941 Methods for treating cancer |
| 05/06/2010 | US20100111940 Compositions containing alpha-1-antitrypsin and methods for use |
| 05/06/2010 | US20100111939 Monoclonal antibody and use thereof |
| 05/06/2010 | US20100111938 Compositions and methods for biological remodeling with frozen particle compositions |
| 05/06/2010 | US20100111937 Modulation of Toll-Like Receptor 5 Expression by Antisense Oligonucleotides |
| 05/06/2010 | US20100111936 Modulation of Toll-Like Receptor 4 Expression by Antisense Oligonucleotides |
| 05/06/2010 | US20100111935 Modulation of Toll-Like Receptor 2 Expression By Antisense Oligonucleotides |
| 05/06/2010 | US20100111934 Determining Immunoglobulins In Non-Blood Body Fluids Of Neonatal Ungulates |
| 05/06/2010 | US20100111933 Acid soluble proteins from micellar casein |
| 05/06/2010 | US20100111932 Antibodies against ramp3 |
| 05/06/2010 | US20100111931 Agents, Which Inhibit Apoptosis in Cells that are Involved in Wound Healing |
| 05/06/2010 | US20100111930 Methods and Compositions for Detecting Receptor Ligand Mimetics |
| 05/06/2010 | US20100111929 Method of treating peripheral nerve disorders |
| 05/06/2010 | US20100111928 Methods and kits for diagnosis tumorgenicity |
| 05/06/2010 | US20100111927 Compositions Comprising Actinidia and Methods of Use Thereof |
| 05/06/2010 | US20100111903 Compositions produced using enteric pathogens and methods of use |
| 05/06/2010 | US20100111901 Triazole inhibitors of aromatase |
| 05/06/2010 | US20100111899 Materials and Methods for Immunizing Against FIV Infection |
| 05/06/2010 | US20100111898 Conjoint therapy for treating fibrotic diseases |
| 05/06/2010 | US20100111869 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
| 05/06/2010 | US20100111868 Monoclonal antibodies for neutralizing anthrax toxin |
| 05/06/2010 | US20100111855 Frozen compositions and methods for piercing a substrate |
| 05/06/2010 | US20100111854 Frozen compositions and methods for piercing a substrate |
| 05/06/2010 | US20100111853 Antibodies that bind to il-12 and methods of purifying the same |
| 05/06/2010 | US20100111852 Anti-Claudin 3 Monoclonal Antibody and Treatment and Diagnosis of Cancer Using the Same |
| 05/06/2010 | US20100111850 Compositions and methods for administering compartmentalized frozen particles |
| 05/06/2010 | US20100111849 Compositions and methods for administering compartmentalized frozen particles |
| 05/06/2010 | US20100111848 Compositions and methods for administering compartmentalized frozen particles |
| 05/06/2010 | US20100111847 Compositions and methods for administering compartmentalized frozen particles |
| 05/06/2010 | US20100111845 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111844 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111842 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111840 Stabilized therapeutic and imaging agents |
| 05/06/2010 | US20100111836 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | US20100111834 Compositions and methods for therapeutic delivery with frozen particles |
| 05/06/2010 | CA2779436A1 Light targeting molecules and uses thereof |
| 05/06/2010 | CA2777837A1 Purification method |
| 05/06/2010 | CA2742049A1 Vaccination with poxvirus vectors via mechanical epidermal disruption |
| 05/06/2010 | CA2742014A1 Toll-like receptor 3 antagonists |
| 05/06/2010 | CA2741863A1 Methods for mediating fibrotic response |
| 05/06/2010 | CA2741798A1 Anti-muc1 antibody |
| 05/06/2010 | CA2741664A1 Method for selective control of helper t cell function |
| 05/06/2010 | CA2741434A1 Drug for treating infections |
| 05/06/2010 | CA2740954A1 Multivalent vaccine composition |
| 05/06/2010 | CA2643496A1 The therapeutic use of igg as a neuroprotective agent |
| 05/05/2010 | EP2182068A1 Use of bacteria for the sensing and killing of cancer cells |
| 05/05/2010 | EP2182066A2 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 05/05/2010 | EP2182065A2 Staphylococcus epidermidis antigens |
| 05/05/2010 | EP2182064A1 Gene expressed in prostate cancer |
| 05/05/2010 | EP2182008A2 Monoclonal anti alpha-D (ITGAD) antibodies for use in the treatment of inflammation |
| 05/05/2010 | EP2182006A2 Compositions and methods for the treatment of immune related diseases |